Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03620643
Title Crizotinib in Lobular Breast, Diffuse Gastric and Triple Negative Lobular Breast Cancer or CDH1-mutated Solid Tumours (ROLo)
Acronym ROLo
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Royal Marsden NHS Foundation Trust
Indications
Therapies
Age Groups: adult | senior
Covered Countries GBR

Facility Status City State Zip Country Details
Beatson West of Scotland Cancer Centre Glasgow United Kingdom Details
Royal Marsden NHS Foundation Trust London SW3 6JJ United Kingdom Details
Guys and St Thomas NHS Foundation Trust London United Kingdom Details
University College London Hospital London United Kingdom Details
The Christie NHS Foundation Trust Manchester United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field